Technical Analysis Free Video Ebook Sign Up



Premier Trading Videos Sign Up



International Stock Trading Sign Up

SMF Services

SMF Blogs > Hot Trends > February 2009 > DNA Genentech: A prenatal link to Alzheimer's?

DNA Genentech: A prenatal link to Alzheimer's?

We have told investors and traders worldwide what it would take the start the rally and this here has to stop and bottom out for the markets to look forward as they have no clarity and therefore the selling keeps up. 

We are going to be teach people how this works going forward in our SMF Economic Club you can sign up now by sending an email to info@stockmarketfunding.com or by calling us today at 702-685-0772 we will be happy to update you so that you can start planning your futures moving forward.   

FREE Sign Up www.stockmarketfunding.com let SMF explain to you what this mean for YOU how you can take advantage of this.


SMF NOTES WSJ reports new research at DNA is challenging conventional thinking about Alzheimer's disease, providing a provocative theory about its cause and suggesting potential new targets for therapies to treat it.

The researchers propose that a normal process in which excess nerve cells and nerve fibers are pruned from the brain during prenatal development is somehow reactivated in the adult brain and "hijacked" to cause the death of such cells in Alzheimer's patients.

The dominant view of Alzheimer's disease today is that it is caused by deposits called beta amyloid that accumulate in the brain because of bad luck or other unknown reasons, degrading and destroying nerve cells and robbing victims of their memory.

The new findings offer evidence that "Alzheimer's is not just bad luck, but rather it is the activation of a pathway that is there for development purposes," says Marc Tessier-Lavigne, executive vice president, research drug discovery, at Genentech. "It suggests a different way of looking at Alzheimer's disease."
 




Prepare yourself for the "New Economy"


 
Posted: 2/19/2009 8:43:42 AM by StockMarketFunding | with 0 comments


Comments There are no comments on this post.